Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

DAS181 inhibits H5N1 Influenza lung virus infection of human lung tissues

NexBio, Inc. announced today the publication "DAS181 Inhibits H5N1 Influenza Lung Virus Infection of Human Lung Tissues" in the September, 2009 issue of the journal Antimicrobial Agents and Chemotherapy (AAC).

26 Aug 2009

Public and private sector players ready to tackle North America’s upcoming flu season

An MIT Sloan School of Management expert on U.S. vaccine markets is “cautiously hopeful” that public and private sector players are far better prepared for North America’s upcoming flu season than they have been for earlier flu pandemics.

26 Aug 2009

Report warns H1N1 could affect half of U.S. population

A U.S. presidential panel report released Monday estimates H1N1 (swine) flu could infect up to half of the country's population, the Washington Post reports.

26 Aug 2009

The University of Nottingham scientists conduct research on swine flu virus

Scientists at The University of Nottingham and Health Protection Agency East Midlands are carrying out urgent research into the swine flu virus after being commissioned as part of the government's response to the pandemic.

26 Aug 2009

U.S. troops serving overseas to be tested for H1N1 infection

The U.S. Food and Drug Administration today announced it has issued an Emergency Use Authorization (EUA) that allows a 2009 H1N1 influenza virus test to be used to detect the virus in troops serving overseas.

26 Aug 2009

Hiberix receives accelerated approval from FDA to overcome nationwide shortage

The U.S. Food and Drug Administration today approved Hiberix, a Haemophilus influenzae Type b (Hib) vaccine, as a booster dose for children 15 months through 4 years old. Hiberix is manufactured by GlaxoSmithKline, with U.S. headquarters in Research Triangle Park, N.C. and Philadelphia.

26 Aug 2009

Aastra's CC:LifeLine provides virtual call center for pandemic response planning

Aastra, a leading provider of IP-Telephony and Contact Center solutions, offers a solution for contact centers needing an alternative for premises-based agents if it is necessary to close the call center due to a disaster or flu epidemic. Aastra’s CC:LifeLine™ (www.aastraondemand.com/solutions-cclifeline2.asp) provides a virtual call center environment ensuring that agents can serve customers even if the physical call center is inaccessible.

25 Aug 2009

PuriCore reduces operating expenses by 14% in H1 2009 when compared with H1 2008

PuriCore (LSE: PURI), the life sciences company focused on developing and commercializing proprietary, green solutions that safely, effectively, and naturally kill infectious pathogens without causing harm to human health or the environment, today announces its interim results for the six months ending June 30, 2009. An H1 2009 Operating and Financial Report and detailed financial results are available here at PuriCore’s website.

25 Aug 2009

Americans' hand-washing habits has not changed despite H1N1 virus reveals a national survey

Worries about the H1N1 virus haven't changed most Americans' hand washing habits, says a national survey by Bradley Corporation, a leading manufacturer of commercial bathroom and locker room furnishings.

25 Aug 2009

Free webinar for business travel industry on swine flu pandemic

"Business as usual” won’t be this flu season, with the effects of the H1N1 (Swine Flu) pandemic expected to include quarantines, travel restrictions and school and office closings. Businesses that rely on travel need to make preparations now to mitigate the impact.

25 Aug 2009

The SaniGuard dry-on-contact sanitising spray is launched by MisterSterile.com

A sanitising spray that kills 99.99% of Viruses, Bacteria and Germs is now available for purchase in the UK. The SaniGuard wipes, spray and fogger products were invented by David Morgan, president of DEM Technology in the United States. After patenting the product he was awarded EPA registration for its use on food contact surfaces in 1996.

25 Aug 2009

Bavarian Nordic begins negotiations with U.S. to secure a contract to develop a freeze-dried version of smallpox vaccine

Bavarian Nordic A/S (OMX: BAVA) announced today that the US authorities have initiated negotiations for a new contract to develop a freeze-dried version of the IMVAMUNE(R) smallpox vaccine.

25 Aug 2009

Unotron collaborates with GHA Technologies to supply washable data input devices

School systems throughout the nation have a strong ally in mitigating a resurgence of swine flu this fall. UNOTRON (www.unotron.com), worldwide creator of medical grade, washable computer keyboards, scroll wheel mice, and smartcard readers, announces that it is teaming up with GHA Technologies, Inc. (www.gha-associates.com) to offer Unotron’s high quality, washable data input and security devices.

25 Aug 2009

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, is accepting grant applications for a new initiative to establish a consortium of human immune profiling research centers.

25 Aug 2009

Pharmacy Times serves as a go-to resource for pharmacists on OTC products

Consumers overwhelmed by options when considering over-the-counter (OTC) medications can now find out which products are most recommended by pharmacists through Pharmacy & Healthcare Communications' OTC Recommendations Survey.

25 Aug 2009

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

UCB and sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved XYZAL(R) (levocetirizine dihydrochloride) for children age six months and older for the relief of symptoms of perennial allergic rhinitis (indoor allergies) and chronic idiopathic urticaria (chronic hives) and for children age two years and older for symptoms of seasonal allergic rhinitis (outdoor allergies).

25 Aug 2009

New technique developed to identify gene copy number variations

A research team led by Associate Professor Jonathan Sebat, Ph.D., of Cold Spring Harbor Laboratory (CSHL) has developed a sensitive and accurate way of identifying gene copy number variations (CNVs).

25 Aug 2009

Health Fair 11 to offer free or low-cost health screenings

Visitors attending the Minnesota State Fair will find some great health deals when they stop by Health Fair 11 at the Fair. More than a dozen organizations will offer free or low-cost health screenings. Among the screenings are: cholesterol testing (non-fasting), diabetes screening (glucose -- non-fasting), blood pressure checks, blood typing, hearing and vision assessments, bone density and body fat measurements, and weight readings.

24 Aug 2009

WHO appeals for donated, low-cost H1N1 vaccines

The WHO's flu chief Keiji Fukuda on Saturday called upon wealthy nations and vaccine manufacturers to donate H1N1 (swine) flu vaccines to developing countries, the Associated Press reports.

24 Aug 2009

CSL Biotherapies initiates clinical trials of Influenza A/H1N1 2009 vaccine in the US

CSL Biotherapies has announced the initiation of the company’s first U.S. clinical trials of its candidate Influenza A/H1N1 2009 vaccine. Study investigators will administer vaccinations to the first U.S. study volunteers today, August 24. The studies will determine the safety of CSL’s candidate vaccine and its ability to elicit an immune response (also referred to as immunogenicity) in adults and children.

24 Aug 2009

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

DAS181 inhibits H5N1 Influenza lung virus infection of human lung tissues

Public and private sector players ready to tackle North America’s upcoming flu season

Report warns H1N1 could affect half of U.S. population

The University of Nottingham scientists conduct research on swine flu virus

U.S. troops serving overseas to be tested for H1N1 infection

Hiberix receives accelerated approval from FDA to overcome nationwide shortage

Aastra's CC:LifeLine provides virtual call center for pandemic response planning

PuriCore reduces operating expenses by 14% in H1 2009 when compared with H1 2008

Americans' hand-washing habits has not changed despite H1N1 virus reveals a national survey

Free webinar for business travel industry on swine flu pandemic

The SaniGuard dry-on-contact sanitising spray is launched by MisterSterile.com

Bavarian Nordic begins negotiations with U.S. to secure a contract to develop a freeze-dried version of smallpox vaccine

Unotron collaborates with GHA Technologies to supply washable data input devices

NIAID to establish a human immune profiling research consortium in 2010; invites grant applications

Pharmacy Times serves as a go-to resource for pharmacists on OTC products

UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children

New technique developed to identify gene copy number variations

Health Fair 11 to offer free or low-cost health screenings

WHO appeals for donated, low-cost H1N1 vaccines

CSL Biotherapies initiates clinical trials of Influenza A/H1N1 2009 vaccine in the US

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in